CorMedix
CRMD
75 hedge funds and large institutions have $68.8M invested in CorMedix in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 8 closing their positions.
142% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 12
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
37% more capital invested
Capital invested by funds: $50.2M → $68.8M (+$18.6M)
6% more funds holding
Funds holding: 71 → 75 (+4)
2.17% more ownership
Funds ownership: 26.66% → 28.83% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less call options, than puts
Call options by funds: $1.7M | Put options by funds: $2.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$816K |
| 2 |
Two Sigma Advisers
New York
|
+$625K |
| 3 |
BlackRock
New York
|
+$604K |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$546K |
| 5 |
Two Sigma Investments
New York
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$645K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
-$377K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$164K |
| 4 |
AGM
Alpine Global Management
New York
|
-$114K |
| 5 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
-$92K |
CRMD Hedge Fund Activity: Q4 2020 in Review
75 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2020, worth a combined $68.8M — up 37% from $50.2M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CRMD positions and 8 closed out — a net gain of 4 holders — while 29 added to existing stakes and 12 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $816K. The largest seller was Millennium Management, exiting entirely with an estimated $645K sold.
- 75 institutional investors held CorMedix (CRMD) as of Q4 2020, up from 71 in Q3 2020.
- Funds reported $68.8M of CorMedix stock for Q4 2020, up 37% quarter-over-quarter.
- 12 funds opened new CorMedix positions in Q4 2020 and 8 closed out, a net change of +4 holders.
- The largest CorMedix buyer in Q4 2020 was EAM Investors, an estimated $816K added.
- The largest CorMedix seller in Q4 2020 was Millennium Management, an estimated $645K sold.
Based on aggregated 13F filings for Q4 2020.